Plasma markers of dyslipidemia (plasma cholesterol), insulin resistance (Homa-IR), and systemic and hepatic inflammation (Tnfα) were significantly increased prior to hepatosteatosis (Fig 3, 4 & 18F) and obesity (Fig 2B). This evidence concerns the gene TNF and metabolic syndrome.